Blockbuster label or lackluster label? Pre-Planning makes the difference. Figuring out, in advance of your pivotal trial, what robust and compelling language you need in your label has become one of the most strategic issues in drug development.
Wendy Balter, Kathryn Bohannon, Jessica Lee and Rohit Sood elaborate in our sponsored IN Vivo article.
This content was repurposed from Pharma intelligence.
